Jornal Brasileiro de Pneumologia · 2022 · 10 citations · 17 references
MedicineRespiratory TherapyCritical Care Respiratory TherapyPulmonologyVentilator ManagementAcute Respiratory FailureBreathing SupportContinuous Positive Airway PressureMechanical VentilationRespiratory FailureRespiratory Failure ManagementAcute Adverse EventsAcute Hypoxemic Respiratory FailureCritical Care VentilationPilot Study DesignRespiratory Status Assessment
OBJECTIVE: To assess the feasibility of using a new helmet interface for CPAP, designated ELMO, to treat COVID-19-related acute hypoxemic respiratory failure (AHRF) outside the ICU. METHODS: This was a proof-of-concept study involving patients with moderate to severe AHRF secondary to COVID-19 admitted to the general ward of a public hospital. The intervention consisted of applying CPAP via the ELMO interface integrated with oxygen and compressed air flow meters (30 L/min each) and a PEEP valve (CPAP levels = 8-10 cmH2O), forming the ELMOcpap system. The patients were monitored for cardiorespiratory parameters, adverse events, and comfort. RESULTS: Ten patients completed the study protocol. The ELMOcpap system was well tolerated, with no relevant adverse effects. Its use was feasible outside the ICU for a prolonged amount of time and was shown to be successful in 60% of the patients. A CPAP of 10 cmH2O with a total gas flow of 56-60 L/min improved oxygenation after 30-to 60-min ELMOcpap sessions, allowing a significant decrease in estimated FIO2 (p = 0.014) and an increase in estimated PaO2/FIO2 ratio (p = 0.008) within the first hour without CO2 rebreathing. CONCLUSIONS: The use of ELMOcpap has proven to be feasible and effective in delivering high-flow CPAP to patients with COVID-19-related AHRF outside the ICU. There were no major adverse effects, and ELMO was considered comfortable. ELMOcpap sessions significantly improved oxygenation, reducing FIO2 without CO2 rebreathing. The overall success rate was 60% in this pilot study, and further clinical trials should be carried out in the future.(ClinicalTrials.gov identifier: NCT04470258 [http://www.clinicaltrials.gov/]).
17
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Ezekiel Emanuel, Govind Persad, Ross Upshur et al. · New England Journal of Medicine · 2020 · 3.2K citations
Bhakti K. Patel, K.S. Wolfe, Anne S. Pohlman et al. · JAMA · 2016 · 558 citations · Full text
Health Professions, Respiratory Therapy, Critical Care Respiratory Therapy +13
Otávio T. Ranzani, Leonardo dos Santos Lourenço Bastos, João Gabriel Mayrinck Gelli et al. · The Lancet Respiratory Medicine · 2021 · 522 citations · Full text
Domenico Luca Grieco, Luca S. Menga, Melania Cesarano et al. · JAMA · 2021 · 499 citations · Full text
Health Professions, Respiratory Therapy, Critical Care Respiratory Therapy +15